CLOVER HEALTH ($CLOV) posted quarterly earnings results on Tuesday, August 5th. The company reported earnings of $0.03 per share, beating estimates of -$0.03 by $0.06. The company also reported revenue of $477,620,000, missing estimates of $477,662,430 by $-42,430.
You can see Quiver Quantitative's $CLOV stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
CLOVER HEALTH Insider Trading Activity
CLOVER HEALTH insiders have traded $CLOV stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.
Here’s a breakdown of recent trading of $CLOV stock by insiders over the last 6 months:
- CARLADENISE ARMBRISTER EDWARDS sold 200,000 shares for an estimated $722,000
- CONRAD WAI (CEO, Counterpart Health) has made 0 purchases and 2 sales selling 209,797 shares for an estimated $692,968.
- BRADY PATRICK PRIEST (CEO of Home Care) sold 75,000 shares for an estimated $276,000
- KAREN SOARES (General Counsel & Secretary) sold 52,500 shares for an estimated $199,500
- JAMIE L. REYNOSO (CEO, Medicare Advantage) has made 0 purchases and 3 sales selling 42,251 shares for an estimated $115,276.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
CLOVER HEALTH Hedge Fund Activity
We have seen 102 institutional investors add shares of CLOVER HEALTH stock to their portfolio, and 88 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MILLENNIUM MANAGEMENT LLC added 4,558,305 shares (+365.9%) to their portfolio in Q1 2025, for an estimated $16,364,314
- BANK OF NEW YORK MELLON CORP added 1,071,195 shares (+1050.8%) to their portfolio in Q2 2025, for an estimated $2,988,634
- VANGUARD GROUP INC added 994,904 shares (+5.1%) to their portfolio in Q1 2025, for an estimated $3,571,705
- BANK OF AMERICA CORP /DE/ added 979,733 shares (+344.7%) to their portfolio in Q1 2025, for an estimated $3,517,241
- CITADEL ADVISORS LLC added 822,712 shares (+90.3%) to their portfolio in Q1 2025, for an estimated $2,953,536
- 8 KNOTS MANAGEMENT, LLC added 817,905 shares (+inf%) to their portfolio in Q1 2025, for an estimated $2,936,278
- MARSHALL WACE, LLP added 805,762 shares (+21.4%) to their portfolio in Q1 2025, for an estimated $2,892,685
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CLOVER HEALTH Analyst Ratings
Wall Street analysts have issued reports on $CLOV in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Canaccord Genuity issued a "Buy" rating on 03/03/2025
To track analyst ratings and price targets for CLOVER HEALTH, check out Quiver Quantitative's $CLOV forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
